Trial intelligence / Profile preview

Treatment of Hypertension Associated With Severe Preeclampsia

2014-002544-40Phase 3Terminated

Sponsor
Strasbourg University Hospital
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of urapidil in hypertension (HTN) and preeclampsia (2 arms), sponsored by Strasbourg University Hospital. Started Jun 2015; status: terminated.

02

Drugs

urapidil
03

Conditions

hypertension (HTN)preeclampsia

Beyond the preview

Go deeper on 2014-002544-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002544-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call